Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
The most recent EPS for Smith & Nephew plc is $, expectations of $.
How did Smith & Nephew plc SNN's revenue perform in the last quarter?
Smith & Nephew plc revenue for the last quarter is $
What is the revenue estimate for Smith & Nephew plc?
According to of Wall street analyst, the revenue estimate of Smith & Nephew plc range from $ to $
What's the earning quality score for Smith & Nephew plc?
Smith & Nephew plc has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Smith & Nephew plc report earnings?
Smith & Nephew plc next earnings report is expected in 2026-08-04
What are Smith & Nephew plc's expected earnings?
Smith & Nephew plc expected earnings is $, according to wall-street analysts.
Did Smith & Nephew plc beat earnings expectations?
Smith & Nephew plc recent earnings of $ expectations.